Endogenous APP accumulates in synapses after BACE1 inhibition

[1]  Xinran Liu,et al.  APP Is Cleaved by Bace1 in Pre-Synaptic Vesicles and Establishes a Pre-Synaptic Interactome, via Its Intracellular Domain, with Molecular Complexes that Regulate Pre-Synaptic Vesicles Functions , 2014, PloS one.

[2]  G. Dolios,et al.  Differential Release of β-Amyloid from Dendrite- Versus Axon-Targeted APP , 2014, The Journal of Neuroscience.

[3]  B. Winblad,et al.  Activity-independent release of the amyloid β-peptide from rat brain nerve terminals , 2014, Neuroscience Letters.

[4]  Virgil Muresan,et al.  Dual-tagged amyloid-β precursor protein reveals distinct transport pathways of its N- and C-terminal fragments. , 2014, Human molecular genetics.

[5]  E. Koo,et al.  Activity-Induced Convergence of APP and BACE-1 in Acidic Microdomains via an Endocytosis-Dependent Pathway , 2013, Neuron.

[6]  L. Goldstein,et al.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects. , 2012, Human molecular genetics.

[7]  Lukas N. Mueller,et al.  Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. , 2012, Journal of proteome research.

[8]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[9]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[10]  C. Haass,et al.  Trafficking and proteolytic processing of APP. , 2012, Cold Spring Harbor perspectives in medicine.

[11]  O. Arancio,et al.  β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia , 2012, Molecular Neurodegeneration.

[12]  K. Blennow,et al.  BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System , 2012, PloS one.

[13]  C. Robertson,et al.  Amyloid Precursor Protein Revisited , 2011, The Journal of Biological Chemistry.

[14]  L. Brodin,et al.  Regulation of Synaptic Vesicle Budding and Dynamin Function by an EHD ATPase , 2011, The Journal of Neuroscience.

[15]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[16]  B. de Strooper,et al.  ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1 , 2011, Proceedings of the National Academy of Sciences.

[17]  C. Thiel,et al.  Amyloid Precursor Protein Is Trafficked and Secreted via Synaptic Vesicles , 2011, PloS one.

[18]  E. Capetillo-Zarate,et al.  Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.

[19]  P. Wong,et al.  BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus , 2008, The Journal of Neuroscience.

[20]  U. Landegren,et al.  Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. , 2008, Methods.

[21]  L. Brodin,et al.  Role of epsin 1 in synaptic vesicle endocytosis , 2008, Proceedings of the National Academy of Sciences.

[22]  Guojun Bu,et al.  Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo , 2008, Neuron.

[23]  H. Cai,et al.  BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions , 2005, The Journal of Neuroscience.

[24]  Alison R. Gregro,et al.  Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1). , 2004, Journal of medicinal chemistry.

[25]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[26]  P. Greengard,et al.  Alzheimer Amyloid Protein Precursor Is Localized in Nerve Terminal Preparations to Rab5-containing Vesicular Organelles Distinct from Those Implicated in the Synaptic Vesicle Pathway* , 1996, The Journal of Biological Chemistry.

[27]  R. Kelly,et al.  Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells , 1985, The Journal of cell biology.

[28]  D. Holtzman,et al.  Deciphering Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.